Omaxe Board Meeting Date

Financial Results

Omaxe Q2 FY27 Results: Net Loss of ₹25.6 Cr, Loss Narrows

Omaxe Ltd reported revenue from operations of ₹575.5 Cr (+79.4% YoY) and a net loss of ₹25.6 Cr for Q2 FY27.

Key figure

Net loss ₹25.6 Cr

Merger & Restructuring

Omaxe Merger & Restructuring Worth ₹0.01 Cr

Omaxe Limited approved incorporating a wholly owned subsidiary for real estate PPP projects. The subsidiary's subscription cost is Rs 1,00,000 for 100% equity.

Value

₹0.01 Cr

Other Announcement

Omaxe Other Announcement

Omaxe Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026.

Product LaunchAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Omaxe Product Launch

Omaxe Ltd announced the launch of a new commercial and service apartment project at 'Eternity - 2', targeting both domestic and international markets.

Regulatory ApprovalAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Omaxe Regulatory Approval

Omaxe Ltd received RERA registration for its 'Eternity - 2' commercial and service apartment project in Mathura. The approval facilitates sales, marketing, and project development.

From

Uttar Pradesh Real Estate Regulatory Authority

Business Update

Omaxe Business Update

Omaxe Limited has received RERA registration for its new 'Commercial and Service Apartment at Eternity - 2' project located in Mathura, Uttar Pradesh.

Board Meeting DateMetropolis Healthcare Ltd METROPOLIS

Metropolis Healthcare Board Meeting Date

Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.

Board Meeting DateAelea Commodities Ltd 544213

Aelea Commodities Board Meeting Date

Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.

Board Meeting DateR Systems International Ltd RSYSTEMS

R Systems International Board Meeting Date

R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.

Board Meeting DateOnida Electronics Ltd ONIDA

Onida Electronics Board Meeting Date

Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.

Board Meeting DatePlatinum Industries Ltd PLATIND

Platinum Industries Board Meeting Date

Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.

Board Meeting DateESDS Software Solution Ltd ESDS

ESDS Software Solution Board Meeting Date

ESDS Software Solution will hold a board meeting on 2 November 2026 to consider unaudited standalone and consolidated results for Q2 and half-year. This is a prior intimation of a future meeting with no decision yet taken.